{"datasetJSONCreationDateTime":"2024-12-18T15:34:17","datasetJSONVersion":"1.1.0","fileOID":"CDISCPILOT01.ti","dbLastModifiedDateTime":"2012-04-04T22:16:22","originator":"CDISC Data Exchange Standards Team","sourceSystem":{"name":"SAS on X64_10PRO","version":"9.0401M7"},"studyOID":"CDISCPILOT01","metaDataVersionOID":"CDISC.SDTMIG.3.1.2","metaDataRef":"define.xml","itemGroupOID":"TI","records":31,"name":"TI","label":"Trial Inclusion/ Exclusion Criteria","columns":[{"itemOID":"TI.STUDYID","name":"STUDYID","label":"Study Identifier","dataType":"string","length":12,"keySequence":1},{"itemOID":"TI.DOMAIN","name":"DOMAIN","label":"Domain Abbreviation","dataType":"string","length":2},{"itemOID":"TI.IETESTCD","name":"IETESTCD","label":"Incl/Excl Criterion Short Name","dataType":"string","length":16,"keySequence":2},{"itemOID":"TI.IETEST","name":"IETEST","label":"Inclusion/Exclusion Criterion","dataType":"string","length":166},{"itemOID":"TI.IECAT","name":"IECAT","label":"Inclusion/Exclusion Category","dataType":"string","length":9},{"itemOID":"TI.TIRL","name":"TIRL","label":"Inclusion/Exclusion Criterion Rule","dataType":"string","length":40}],"rows":[["CDISCPILOT01","TI","INCL01","Males and postmenopausal females at least 50 years of age.","INCLUSION",""],["CDISCPILOT01","TI","INCL02","Diagnosis of probable AD as defined by NINCDS and the ADRDA guidelines (Protocol Attachment LZZT.7).","INCLUSION",""],["CDISCPILOT01","TI","INCL03","MMSE score of 10 to 23.","INCLUSION",""],["CDISCPILOT01","TI","INCL04","Modified Hachinski Ischemic Scale score of <= 4. (Protocol Attachment LZZT.8).","INCLUSION",""],["CDISCPILOT01","TI","INCL05","CNS imaging (CT scan or MRI of brain) compatible with AD within past 1 year.","INCLUSION",""],["CDISCPILOT01","TI","INCL06","Investigator has obtained informed consent signed by the patient (and/or legal representative) and by the caregiver.","INCLUSION",""],["CDISCPILOT01","TI","INCL07","Geographic proximity to investigator's site that allows adequate follow-up.","INCLUSION",""],["CDISCPILOT01","TI","INCL08","Caregiverwill monitor administration of prescribed medications, and will be responsible for the overall care of the patient at home.","INCLUSION",""],["CDISCPILOT01","TI","EXCL09","Persons who have previously completed or withdrawn from this study or any other investigating xanomeline TTS or the oral formulation of xanomeline.","EXCLUSION",""],["CDISCPILOT01","TI","EXCL10","Use of any investigational agent or approved Alzheimer's therapeutic medication within 30 days prior to enrollment into the study.","EXCLUSION",""],["CDISCPILOT01","TI","EXCL11","Serious illness which required hospitalization within 3 months of screening.","EXCLUSION",""],["CDISCPILOT01","TI","EXCL12","Diagnosis of serious neurological conditions.","EXCLUSION",""],["CDISCPILOT01","TI","EXCL13","Episode of depression meeting DSM-IV criteria within 3 months of screening.","EXCLUSION",""],["CDISCPILOT01","TI","EXCL14","A history of mental illness within the last 5 years.","EXCLUSION",""],["CDISCPILOT01","TI","EXCL15","A history of syncope within the last 5 years.","EXCLUSION",""],["CDISCPILOT01","TI","EXCL16","Evidence from ECG recording at screening of any listed condition.","EXCLUSION",""],["CDISCPILOT01","TI","EXCL17","A history within the last 5 years of a serious cardiovascular disorder.","EXCLUSION",""],["CDISCPILOT01","TI","EXCL18","A history within the last 5 years of a serious gastrointestinal disorder.","EXCLUSION",""],["CDISCPILOT01","TI","EXCL19","A history within the last 5 years of a serious endocrine disorder.","EXCLUSION",""],["CDISCPILOT01","TI","EXCL20","A history within the last 5 years of a serious respiratory disorder (see list).","EXCLUSION",""],["CDISCPILOT01","TI","EXCL21","A history within the last 5 years of a serious genitourinary disorder.","EXCLUSION",""],["CDISCPILOT01","TI","EXCL22","A history within the last 5 years of a serious rheumatologic disorder.","EXCLUSION",""],["CDISCPILOT01","TI","EXCL23","A known history of human immunodeficiency virus (HIV) within the last 5 years.","EXCLUSION",""],["CDISCPILOT01","TI","EXCL24","A history within the last 5 years of a serious infectious disease (see list in protocol).","EXCLUSION",""],["CDISCPILOT01","TI","EXCL25","A history within the last 5 years of a primary or recurrent malignant disease (with exceptions, see list in protocol).","EXCLUSION",""],["CDISCPILOT01","TI","EXCL26","Visual, hearing, or communication disabilities impairing the ability to participate in the study; (for example, inability to speak or understand English, illiteracy).","EXCLUSION",""],["CDISCPILOT01","TI","EXCL27","Laboratory test values exceeding the Lilly Reference Range III for the patient's age in any of the following analytes: creatinine, total bilirubin, SGOT, SGPT, etc.","EXCLUSION",""],["CDISCPILOT01","TI","EXCL28","Central laboratory test values below reference range for folate, and vitamin B12, and outside reference range for thyroid function tests.","EXCLUSION",""],["CDISCPILOT01","TI","EXCL29","Positive syphilis screening with confirmatory testing.","EXCLUSION",""],["CDISCPILOT01","TI","EXCL30","Central laboratory test value above reference range for glycosylated hemoglobin (A1C) (insulin dependent diabetes mellitus patients only).","EXCLUSION",""],["CDISCPILOT01","TI","EXCL31","Treatment with medications within 1 month prior to enrollment (see list).","EXCLUSION",""]]}